Preclinical toxicology and pharmacology of drugs

Ended Definitive Contract Awarded Last action

Contract number
HHSN261200422000C
Awardee
Awarding agency
Obligated
$10,766,668

Award facts

Opportunity
  • N01CM3703919 Solicitation number
Contract value 12% obligated
$91,567,452.38 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
Set-aside
No set-aside
Competition
Full and Open Competition · 8 offers
Pricing
Cost Plus Fixed Fee
Place of performance
Columbus, OH 43201, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action 24 · Modified to remove all remaining funds per 12/17 email that all funding must be removed from LOC contracts that wont be closed by 12/24/15. -$295,298
Funding Only Action 23 · Amended to deobligate FY10 funding. -$33,923
Other Administrative Action 22 · Amended to administratively update the central point of distription in the payment office field $0
Other Administrative Action 21 $0
Change Order 20 $295,298
Funding Only Action 19 $492,062
Funding Only Action 18 $859,422
Funding Only Action 17 $633,896
Funding Only Action 16 $175,000
Funding Only Action 15 $948,868
Other Administrative Action 14 $0
Funding Only Action 13 $43,000
Funding Only Action 12 $700,000
Funding Only Action 11 $830,594
Other Administrative Action 10 $0
Funding Only Action 9 $843,000
Funding Only Action 8 $801,062
Funding Only Action 7 $772,636
Funding Only Action 6 $772,636
Other Administrative Action 5 $0
Funding Only Action 4 $490,548
Funding Only Action 3 $1,000,000
Funding Only Action 2 $271,641
Funding Only Action 1 $447,292
Original award $718,934
Show all 25

About this award

Written by GovTribe AI ·

This is a Cost Plus Fixed Fee definitive contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Battelle Memorial Institute (doing business as Battelle) for $91,567,452.38. The contract is for preclinical toxicology and pharmacology services related to the development of drugs. There is no set-aside designation indicated. Battelle is a large, non-profit research and development organization that frequently provides research, engineering, testing, and other technical services to federal government agencies. This contract represents one of Battelle's many prime contract awards, leveraging its broad scientific and technical capabilities to support the National Cancer Institute's drug development programs.

Quick answers

Who was awarded contract HHSN261200422000C?

HHSN261200422000C was awarded to Battelle Memorial Institute by National Cancer Institute (National Institutes of Health) on April 1, 2004.

How much is contract HHSN261200422000C worth?

The government has obligated $10,766,668 on HHSN261200422000C. Its current value, with exercised options, is $91,567,452.

Was contract HHSN261200422000C competed?

The extent of competition for HHSN261200422000C was full and open competition. The government received 8 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login